May 5, 2026 04:01PM
Apr 2, 2026 12:00PM
Apr 2, 2026 10:46AM
Apr 2, 2026 08:31AM
Apr 2, 2026 08:30AM
Mar 30, 2026 08:32AM
Mar 30, 2026 08:30AM Ultragenyx Announces FDA Clearance of Investigational New Drug (IND) Application for UX016, a Sialic Acid Prodrug for the Treatment of GNE Myopathy
Feb 23, 2026 08:30AM
Feb 23, 2026 08:30AM
Feb 18, 2026 06:44AM
Feb 12, 2026 04:01PM
Feb 3, 2026 06:44AM
Jan 30, 2026 08:31AM
Jan 30, 2026 08:30AM Ultragenyx Resubmits Biologics License Application for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA) to U.S. FDA
Jan 12, 2026 07:31AM
Jan 12, 2026 07:30AM
Dec 30, 2025 04:06PM
Dec 30, 2025 04:05PM
Dec 30, 2025 04:58AM
Dec 30, 2025 02:03AM
Dec 29, 2025 01:50PM TD Cowen Reiterates Buy Rating on Ultragenyx Pharma (RARE)
Dec 29, 2025 08:30AM
Dec 29, 2025 08:30AM
Nov 4, 2025 04:05PM
Oct 30, 2025 08:00AM
Sep 8, 2025 04:05PM
Sep 8, 2025 04:05PM
Aug 18, 2025 08:06AM Ultragenyx begins rolling FDA submission for GSDIa gene therapy
Aug 18, 2025 08:00AM
Aug 5, 2025 04:01PM
Jul 31, 2025 04:05PM
Jul 31, 2025 04:05PM
Jul 14, 2025 08:01AM
Jul 14, 2025 08:00AM
Jul 11, 2025 05:05PM Ultragenyx stock falls after FDA issues complete response letter for gene therapy
Jul 11, 2025 04:30PM
Jul 11, 2025 04:30PM
Jul 9, 2025 04:05PM
Jul 9, 2025 04:05PM
Jun 27, 2025 08:00AM
Jun 27, 2025 08:00AM
May 6, 2025 04:01PM Ultragenyx Reports First Quarter 2025 Financial Results and Corporate Update
Feb 19, 2025 07:13AM
Feb 18, 2025 08:07AM
Feb 18, 2025 08:00AM
Feb 13, 2025 04:01PM
Feb 5, 2025 08:00AM
Feb 5, 2025 08:00AM
Jan 12, 2025 11:00AM Ultragenyx Reports Preliminary 2024 Revenue, Financial Guidance for 2025, Pipeline Updates, and 2025 Milestones
Jan 6, 2025 02:00AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All